US Stock MarketDetailed Quotes

COCP Cocrystal Pharma

Watchlist
  • 2.0718
  • +0.0318+1.56%
Close Oct 18 16:00 ET
  • 2.0718
  • 0.00000.00%
Post 20:01 ET
21.08MMarket Cap-1183P/E (TTM)

Cocrystal Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
33.33%-3.7M
-44.74%-4.5M
31.58%-14.67M
32.03%-3.33M
69.90%-2.68M
-48.98%-5.55M
20.43%-3.11M
-62.97%-21.44M
-45.80%-4.89M
-64.87%-8.91M
Net income from continuing operations
-28.25%-5.34M
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
Operating gains losses
----
----
----
----
----
----
----
75.51%-12K
--0
--0
Depreciation and amortization
36.13%211K
-28.57%35K
-457.73%-1.39M
-1,800.00%-1.7M
10.20%108K
63.16%155K
-48.42%49K
1.57%388K
3.09%100K
0.00%98K
Other non cash items
----
----
847.85%1.56M
3,254.55%1.74M
-9.62%-57K
----
----
-187.45%-209K
-114.29%-55K
-6.12%-52K
Change In working capital
184.82%1.36M
-142.52%-739K
186.36%2.34M
258.56%945K
136.31%1.26M
-220.47%-1.6M
6,852.00%1.74M
-1,695.29%-2.71M
-835.80%-596K
-104.24%-3.47M
-Change in receivables
-457.22%-693K
52.92%-113K
75.70%-174K
52.51%-340K
-34.97%212K
159.51%194K
---240K
-228.78%-716K
-12,033.33%-716K
130.64%326K
-Change in prepaid assets
646.34%1.22M
957.89%201K
128.06%470K
-86.78%69K
109.57%218K
127.78%164K
137.50%19K
-891.12%-1.68M
201.73%522K
-341.28%-2.28M
-Change in payables and accrued expense
----
-145.03%-883K
737.38%2.05M
402.49%1.22M
----
----
11,435.29%1.96M
-47.93%-321K
-310.20%-402K
-1,176.47%-1.52M
-Change in other current assets
----
61.11%87K
----
----
----
----
--54K
----
----
----
-Change in other current liabilities
----
44.64%-31K
----
----
----
----
---56K
----
----
----
Cash from discontinued investing activities
Operating cash flow
33.33%-3.7M
-44.74%-4.5M
31.58%-14.67M
32.03%-3.33M
69.90%-2.68M
-48.98%-5.55M
20.43%-3.11M
-68.53%-21.44M
-67.45%-4.89M
-64.87%-8.91M
Investing cash flow
Cash flow from continuing investing activities
0
82.22%-8K
-59.46%-118K
-391.67%-59K
0
-14K
-45K
-42.31%-74K
-50.00%-12K
-1,450.00%-62K
Net PPE purchase and sale
--0
82.22%-8K
-59.46%-118K
-391.67%-59K
--0
---14K
---45K
-42.31%-74K
-50.00%-12K
-1,450.00%-62K
Cash from discontinued investing activities
Investing cash flow
--0
82.22%-8K
-59.46%-118K
-391.67%-59K
--0
---14K
---45K
-42.31%-74K
-50.00%-12K
-1,450.00%-62K
Financing cash flow
Cash flow from continuing financing activities
0
0
14,888.89%3.99M
0
0
57,242.86%4M
-16.67%-7K
-100.07%-27K
22.22%-7K
36.36%-7K
Net issuance payments of debt
--0
--0
74.07%-7K
--0
--0
--0
-16.67%-7K
30.77%-27K
22.22%-7K
36.36%-7K
Net common stock issuance
----
----
--4M
--0
--0
----
----
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
--0
14,888.89%3.99M
--0
--0
57,242.86%4M
-16.67%-7K
-100.07%-27K
22.22%-7K
36.36%-7K
Net cash flow
Beginning cash position
-35.64%21.92M
-28.99%26.43M
-36.65%37.22M
-29.24%29.81M
-36.42%32.49M
-37.90%34.06M
-36.65%37.22M
77.72%58.76M
-31.71%42.13M
-23.85%51.11M
Current changes in cash
-136.81%-3.7M
-42.62%-4.51M
49.89%-10.79M
31.78%-3.39M
69.97%-2.68M
58.13%-1.56M
19.23%-3.16M
-183.81%-21.54M
-68.83%-4.96M
-64.77%-8.93M
End cash Position
-43.93%18.22M
-35.64%21.92M
-28.99%26.43M
-28.99%26.43M
-29.24%29.81M
-36.42%32.49M
-37.90%34.06M
-36.65%37.22M
-36.65%37.22M
-31.71%42.13M
Free cash flow
33.50%-3.7M
-42.93%-4.51M
31.27%-14.78M
30.99%-3.39M
70.11%-2.68M
-49.36%-5.56M
19.28%-3.16M
-68.42%-21.51M
-67.41%-4.91M
-65.90%-8.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 33.33%-3.7M-44.74%-4.5M31.58%-14.67M32.03%-3.33M69.90%-2.68M-48.98%-5.55M20.43%-3.11M-62.97%-21.44M-45.80%-4.89M-64.87%-8.91M
Net income from continuing operations -28.25%-5.34M23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M
Operating gains losses ----------------------------75.51%-12K--0--0
Depreciation and amortization 36.13%211K-28.57%35K-457.73%-1.39M-1,800.00%-1.7M10.20%108K63.16%155K-48.42%49K1.57%388K3.09%100K0.00%98K
Other non cash items --------847.85%1.56M3,254.55%1.74M-9.62%-57K---------187.45%-209K-114.29%-55K-6.12%-52K
Change In working capital 184.82%1.36M-142.52%-739K186.36%2.34M258.56%945K136.31%1.26M-220.47%-1.6M6,852.00%1.74M-1,695.29%-2.71M-835.80%-596K-104.24%-3.47M
-Change in receivables -457.22%-693K52.92%-113K75.70%-174K52.51%-340K-34.97%212K159.51%194K---240K-228.78%-716K-12,033.33%-716K130.64%326K
-Change in prepaid assets 646.34%1.22M957.89%201K128.06%470K-86.78%69K109.57%218K127.78%164K137.50%19K-891.12%-1.68M201.73%522K-341.28%-2.28M
-Change in payables and accrued expense -----145.03%-883K737.38%2.05M402.49%1.22M--------11,435.29%1.96M-47.93%-321K-310.20%-402K-1,176.47%-1.52M
-Change in other current assets ----61.11%87K------------------54K------------
-Change in other current liabilities ----44.64%-31K-------------------56K------------
Cash from discontinued investing activities
Operating cash flow 33.33%-3.7M-44.74%-4.5M31.58%-14.67M32.03%-3.33M69.90%-2.68M-48.98%-5.55M20.43%-3.11M-68.53%-21.44M-67.45%-4.89M-64.87%-8.91M
Investing cash flow
Cash flow from continuing investing activities 082.22%-8K-59.46%-118K-391.67%-59K0-14K-45K-42.31%-74K-50.00%-12K-1,450.00%-62K
Net PPE purchase and sale --082.22%-8K-59.46%-118K-391.67%-59K--0---14K---45K-42.31%-74K-50.00%-12K-1,450.00%-62K
Cash from discontinued investing activities
Investing cash flow --082.22%-8K-59.46%-118K-391.67%-59K--0---14K---45K-42.31%-74K-50.00%-12K-1,450.00%-62K
Financing cash flow
Cash flow from continuing financing activities 0014,888.89%3.99M0057,242.86%4M-16.67%-7K-100.07%-27K22.22%-7K36.36%-7K
Net issuance payments of debt --0--074.07%-7K--0--0--0-16.67%-7K30.77%-27K22.22%-7K36.36%-7K
Net common stock issuance ----------4M--0--0----------0--0--0
Cash from discontinued financing activities
Financing cash flow --0--014,888.89%3.99M--0--057,242.86%4M-16.67%-7K-100.07%-27K22.22%-7K36.36%-7K
Net cash flow
Beginning cash position -35.64%21.92M-28.99%26.43M-36.65%37.22M-29.24%29.81M-36.42%32.49M-37.90%34.06M-36.65%37.22M77.72%58.76M-31.71%42.13M-23.85%51.11M
Current changes in cash -136.81%-3.7M-42.62%-4.51M49.89%-10.79M31.78%-3.39M69.97%-2.68M58.13%-1.56M19.23%-3.16M-183.81%-21.54M-68.83%-4.96M-64.77%-8.93M
End cash Position -43.93%18.22M-35.64%21.92M-28.99%26.43M-28.99%26.43M-29.24%29.81M-36.42%32.49M-37.90%34.06M-36.65%37.22M-36.65%37.22M-31.71%42.13M
Free cash flow 33.50%-3.7M-42.93%-4.51M31.27%-14.78M30.99%-3.39M70.11%-2.68M-49.36%-5.56M19.28%-3.16M-68.42%-21.51M-67.41%-4.91M-65.90%-8.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data